Omron (OTCMKTS:OMRNY) Stock Price Up 5.9% – Here’s Why

Omron Corp. (OTCMKTS:OMRNYGet Free Report)’s stock price was up 5.9% during trading on Friday . The stock traded as high as $33.11 and last traded at $33.06. Approximately 4,672 shares changed hands during trading, a decline of 91% from the average daily volume of 49,645 shares. The stock had previously closed at $31.2150.

Analysts Set New Price Targets

Separately, Zacks Research raised Omron from a “strong sell” rating to a “hold” rating in a research report on Monday, January 19th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.

Check Out Our Latest Research Report on Omron

Omron Price Performance

The business has a fifty day moving average of $26.63 and a 200 day moving average of $26.72. The firm has a market cap of $6.89 billion, a P/E ratio of 42.28, a PEG ratio of 0.62 and a beta of 0.98. The company has a quick ratio of 1.40, a current ratio of 2.14 and a debt-to-equity ratio of 0.13.

Omron (OTCMKTS:OMRNYGet Free Report) last released its quarterly earnings data on Thursday, February 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). The business had revenue of $1.41 billion during the quarter, compared to analyst estimates of $1.38 billion. Omron had a net margin of 2.80% and a return on equity of 2.46%. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. On average, sell-side analysts anticipate that Omron Corp. will post 0.42 earnings per share for the current year.

Hedge Funds Weigh In On Omron

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC raised its position in Omron Corp. (OTCMKTS:OMRNYFree Report) by 50.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,129 shares of the company’s stock after buying an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 1.09% of the company’s stock.

About Omron

(Get Free Report)

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.

Featured Articles

Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.